TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›NNOX
NNOX logo

NNOX

Nano-X Imaging Ltd.

Next earnings Jun 25, 2026 (before open) · consensus $-0.20 EPS, $4.62M rev

Hold
$1.30
▲ +7.44%
$1.30▼ -75.14%
over 1Y
L $0.88H $5.47
Today+7.4%
1W+47.8%
1M-32.3%
3M-46.1%
YTD-54.1%
1Y-75.1%
OverviewFinancialsValuationQualityFilings
Rating
Hold
Quality
D
Valuation
Fair value
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 9 analysts
Buy

Revenue grew 15.4% YoY; but unprofitable (net margin -576.1%).

Revenue (FY2025) $13.0M · FY2025

Nano-X Imaging Ltd. shows $13.0M in FY2025 revenue (+15.4% YoY), a -576.1% net margin, and -53.7% ROE.

Supporting the case: revenue grew 15.4% YoY; conservative balance sheet (liabilities/equity 0.16x).

Is NNOX a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Covered call~60d expiry
  • Long 100 shares @ ~1.30
  • Short call 1.5 @ ~0.35 est
debit $95max +$55max −$94BE 0.95

HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$1.30M$8.58M$9.90M$11.3M$13.0M
Gross profit-$1.51M-$6.88M-$6.59M-$10.6M-$12.8M
Operating income-$61.6M-$118M-$62.6M-$56.7M-$78.2M
Net income-$61.8M-$113M-$60.8M-$53.5M-$75.0M
Diluted EPS-$1.28-$2.17-$1.08-$0.91-$1.16
Net margin-4739.1%-1320.2%-613.6%-474.3%-576.1%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$47.9M
EV / EBITDA—
EV / Sales3.7
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-82.9%
FCF yield-49.7%

Quality & risk

ROIC (est.)-42.2%
Free cash flow-$45.0M
Total debt$6.62M
Net cash$42.5M
Altman Z-Score-2.60 distress
Piotroski F-Score2/8

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+9.1%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Recent filings

all on EDGAR ↗
6-KPeriod ending 2026-06-252026-06-25open ↗4Period ending 2026-06-102026-06-15open ↗SCHEDULE 13G/AFiling2026-05-15open ↗20-FPeriod ending 2025-12-312026-04-30open ↗3Period ending 2026-03-182026-04-30open ↗6-KPeriod ending 2026-04-202026-04-20open ↗3Period ending 2026-03-182026-04-09open ↗3Period ending 2026-03-182026-04-07open ↗3Period ending 2026-03-182026-04-07open ↗EFFECTFiling2026-03-30open ↗F-3/AFiling2026-03-26open ↗CORRESPFiling2026-03-26open ↗

Quality score

D
ValueGrowthProfitHealthMom.
ValueC
GrowthD
ProfitabilityF
Financial healthB-
MomentumF
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
0.8852-week5.47
Revenue
$13.0M
+15.4% YoY
Net margin
-576.1%
ROE
-53.7%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$13.0M+15.4%
Net income-$75.0M-40.2%
Gross profit-$12.8M-20.5%
Operating income-$78.2M-37.9%
Diluted EPS-$1.16-27.5%
Cash & equivalents$49.2M+25.1%
Total assets$162M-22.8%
Total liabilities$22.4M+7.4%
Stockholders' equity$140M-26.1%
Gross: -98.2%Op.: -600.8%L/E: 0.16x

Frequently asked

Is Nano-X Imaging Ltd. (NNOX) a buy?
NNOX currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 15.4% YoY; but unprofitable (net margin -576.1%).
What is Nano-X Imaging Ltd.'s quality score?
NNOX scores 44.62856460088099/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001795251, latest 6-K filed 2026-06-25) · EODHD · as of 7/5/2026, 1:43:19 AM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

Rule-based analysis, generated automatically from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 9:43 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 2 sales

2026-06-10
Alroy Erez
Director
Sell209.00 @ $1.65$344.85
2026-06-10
Alroy Erez
Director
Sell469.00 @ $1.65$773.85
2026-03-18
Daniel Ran
CFO
Acquired (D)39.5K
2025-09-05
Daniel Ran
CFO
Buy1.00K @ $3.65$3.65K

Held by tracked funds

Form 13F · SEC · quarterly
ARK Investment ManagementCathie Wood733K sh$1.66M

As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →

Recent news

market news →
Bronstein, Gewirtz & Grossman LLC Urges Nano-X Imaging Ltd. Investors to Act: Class Action Filed Alleging Investor HarmBearish
globenewswire.com· 2026-07-02
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NNOXBullish
globenewswire.com· 2026-07-02
DEADLINE ALERT for ERAS, NNOX, MSFT, BRCB: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class ActionsBearish
globenewswire.com· 2026-07-01
DEADLINE ALERT for BTGO, ERAS, NNOX, and MSTF: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of ShareholdersBearish
globenewswire.com· 2026-07-01
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Nano-X Imaging Ltd. (NNOX), Peabody Energy Corporation (BTU), and First Solar, Inc. (FSLR) Announced by Holzer & Holzer, LLCBearish
globenewswire.com· 2026-07-01
Lost Money on Nano-X Imaging Ltd. (NNOX)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyBearish
globenewswire.com· 2026-06-29

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score45 vs 67
Revenue growth15.4% vs 7.5%
Net margin-576.1% vs 10.0%
Return on equity-53.7% vs 12.0%
P/E— vs 26.2